- Home
- PGEN vs IIIV Comparison
PGEN vs IIIV Comparison
Compare PGEN & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- IIIV
- Stock Information
- Founded
- PGEN 1998
- IIIV 2012
- Country
- PGEN United States
- IIIV United States
- Employees
- PGEN N/A
- IIIV N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- IIIV EDP Services
- Sector
- PGEN Health Care
- IIIV Technology
- Exchange
- PGEN Nasdaq
- IIIV Nasdaq
- Market Cap
- PGEN 577.0M
- IIIV 570.8M
- IPO Year
- PGEN N/A
- IIIV 2018
- Fundamental
- Price
- PGEN $1.91
- IIIV $27.71
- Analyst Decision
- PGEN Buy
- IIIV Buy
- Analyst Count
- PGEN 5
- IIIV 7
- Target Price
- PGEN $7.00
- IIIV $29.86
- AVG Volume (30 Days)
- PGEN 2.0M
- IIIV 264.5K
- Earning Date
- PGEN 03-18-2025
- IIIV 02-06-2025
- Dividend Yield
- PGEN N/A
- IIIV N/A
- EPS Growth
- PGEN N/A
- IIIV 21740.15
- EPS
- PGEN N/A
- IIIV 4.87
- Revenue
- PGEN $3,963,000.00
- IIIV $236,560,000.00
- Revenue This Year
- PGEN N/A
- IIIV $12.59
- Revenue Next Year
- PGEN $402.12
- IIIV $8.24
- P/E Ratio
- PGEN N/A
- IIIV $8.02
- Revenue Growth
- PGEN N/A
- IIIV 20.85
- 52 Week Low
- PGEN $0.65
- IIIV $18.75
- 52 Week High
- PGEN $2.17
- IIIV $29.80
- Technical
- Relative Strength Index (RSI)
- PGEN 68.55
- IIIV 57.83
- Support Level
- PGEN $1.63
- IIIV $27.96
- Resistance Level
- PGEN $2.17
- IIIV $29.66
- Average True Range (ATR)
- PGEN 0.18
- IIIV 1.19
- MACD
- PGEN 0.02
- IIIV -0.00
- Stochastic Oscillator
- PGEN 71.74
- IIIV 61.86
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About IIIV i3 Verticals Inc.
i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.